We are live on ! Find out more
PC

Polar Capital Portfolio holdings

AUM $13.5B
1-Year Est. Return 55.9%
This Fund
S&P 500
This Quarter Est. Return
-5.07%
1 Year Est. Return
+55.9%
3 Year Est. Return
+127.44%
5 Year Est. Return
+269.08%
10 Year Est. Return
AUM
$4.94B
AUM Growth
-$256M
Cap. Flow
+$155M
Cap. Flow %
3.13%
Top 10 Hldgs %
23%
Holding
310
New
46
Increased
109
Reduced
88
Closed
39

Top Buys

Rank Stock Value
1
AGN
Allergan plc
AGN
+$52.6M
2
UNH icon
UnitedHealth
UNH
+$48.5M
3
LLY icon
Eli Lilly
LLY
+$40.2M
4
BAC icon
Bank of America
BAC
+$33.6M
5
PFE icon
Pfizer
PFE
+$32.9M

Sector Composition

Rank Sector Weight
1 Healthcare 25.89%
2 Technology 24.22%
3 Financials 21.01%
4 Communication Services 9.7%
5 Consumer Discretionary 6.11%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NXPI icon
101
NXP Semiconductors
NXPI
$67.6B
$16.6M 0.34%
190,381
-47,725
-20% -$4.3M
TSRO
102
DELISTED
TESARO, Inc.
TSRO
$16M 0.32%
+400,000
New +$21.9M
SYNA icon
103
Synaptics
SYNA
$4.55B
$15.8M 0.32%
192,150
+86,967
+83% +$6.57M
SIMO icon
104
Silicon Motion
SIMO
$8.29B
$15.5M 0.31%
568,509
+267,238
+89% +$7.16M
MD icon
105
Pediatrix Medical
MD
$2.15B
$15.4M 0.31%
+200,000
New +$16.1M
NTES icon
106
NetEase
NTES
$79.2B
$15.3M 0.31%
637,675
+202,715
+47% +$5.22M
ANET icon
107
Arista Networks
ANET
$215B
$15.2M 0.31%
3,979,488
+2,013,376
+102% +$9.59M
RTX icon
108
RTX Corp
RTX
$294B
$14.9M 0.3%
265,682
-5,047
-2% -$311K
BIDU icon
109
Baidu
BIDU
$35.8B
$14.8M 0.3%
107,671
-74,155
-41% -$12.2M
RNR icon
110
RenaissanceRe
RNR
$13.7B
$14.6M 0.3%
137,500
+10,000
+8% +$1.05M
ELGX
111
DELISTED
Endologix Inc
ELGX
$14.3M 0.29%
116,715
+6,615
+6% +$898K
OXFD
112
DELISTED
Oxford Immunotec Global PLC Ordinary Shares
OXFD
$14.2M 0.29%
1,048,618
+175,629
+20% +$2.38M
WRB icon
113
W.R. Berkley
WRB
$28.1B
$14.1M 0.29%
877,500
-37,125
-4% -$608K
PPLI
114
People Inc
PPLI
$3.15B
$13.5M 0.27%
1,160,415
+171,802
+17% +$2.28M
MA icon
115
Mastercard
MA
$487B
$13.5M 0.27%
149,675
-84,128
-36% -$7.9M
AXS icon
116
AXIS Capital
AXS
$8.63B
$13.4M 0.27%
250,000
+4,000
+2% +$222K
BRO icon
117
Brown & Brown
BRO
$23.6B
$13M 0.26%
837,000
SPNT icon
118
SiriusPoint
SPNT
$3.01B
$12.6M 0.25%
935,000
HIMX
119
Himax Technologies
HIMX
$2.22B
$12.6M 0.25%
1,578,421
+434,645
+38% +$3.23M
TXN icon
120
Texas Instruments
TXN
$255B
$12.6M 0.25%
253,918
-70,340
-22% -$3.43M
TCOM icon
121
Trip.com Group
TCOM
$28.2B
$12.5M 0.25%
+396,990
New +$13.8M
CRTO icon
122
Criteo
CRTO
$1.05B
$12.5M 0.25%
333,676
+49,964
+18% +$2.29M
ABBV icon
123
AbbVie
ABBV
$454B
$12.5M 0.25%
230,132
-341,868
-60% -$22.3M
HAR
124
DELISTED
Harman International Industries
HAR
$12.4M 0.25%
129,090
+2,121
+2% +$223K
CIVI
125
DELISTED
Civitas Solutions, Inc.
CIVI
$12.2M 0.25%
531,076
+261,777
+97% +$6.25M

Similar funds

Polar Capital's Q3 2015 Portfolio in Review

As of Q3 2015, Polar Capital held 310 positions worth $4.94B, down 4.9% from $5.2B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Polar Capital deployed $155M of net new capital in Q3 2015, opening 46 new positions and adding to 109 existing holdings. Its largest new stake was Allergan plc: 171,100 shares worth $46.5M.

By sector, the portfolio is most concentrated in Healthcare at 26% of assets, up from 24% a quarter earlier, followed by Technology and Financials.

On the sell side, the largest reduction was Thermo Fisher Scientific, an estimated $45M trimmed.

  • Polar Capital's largest Q3 2015 buy was Allergan plc: 171,100 shares worth $46.5M.
  • Polar Capital added most to UnitedHealth in Q3 2015, an estimated $48.5M increase.
  • Polar Capital's biggest Q3 2015 reduction was Thermo Fisher Scientific, cutting an estimated $45M.
  • Polar Capital fully exited Time Warner Inc in Q3 2015, selling an estimated $55.2M.
  • Polar Capital's ten largest holdings make up 23% of its $4.94B portfolio in Q3 2015.
  • Polar Capital opened 46 new positions and closed 39 in Q3 2015.
  • Polar Capital's portfolio value fell 4.9% quarter-over-quarter to $4.94B.

Based on Polar Capital's 13F filing for Q3 2015, filed 16 Nov 2015.